Chromadex Revenue 2024

The Chromadex Revenue history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)
2026e	140.66	36,10
2025e	116.66	43,53
2024e	99.53	51,02
2023	83.57	60,76
2022	72.05	59,40
2021	67.45	61,51
2020	59.26	59,52
2019	46.29	55,67
2018	31.56	50,89
2017	21.2	49,43
2016	21.66	47,97
2015	22.01	38,53
2014	15.31	34,81
2013	10.16	30,81
2012	11.61	19,64
2011	8.11	30,46
2010	7.57	38,84
2009	5.78	35,29
2008	4.51	27,27
2007	4.75	34,32
2006	-	-

Chromadex Aktienanalyse

What does Chromadex do?

The Chromadex Corp was founded in 1999 and is headquartered in Irvine, California. It is a company that specializes in the manufacturing and sale of innovative dietary supplements, pharmaceuticals, and cosmetic products. Business model: Chromadex Corp is primarily a research and development company that aims to create innovative products based on the latest scientific findings. The company has acquired numerous patents and licenses that are used in the development of its products. It offers its products directly to consumers as well as to third parties such as health and wellness companies. Divisions: The company has three main divisions: 1. ChromaDex Sciences: This division is involved in the research and development of products and medications based on modern scientific knowledge. ChromaDex Sciences has successful collaborations with renowned institutions such as the University of Mississippi and UC Davis. 2. NutraIngredients-USA: This division focuses on the distribution of dietary supplements and ingredients that are aimed at improving health and well-being. The company offers a wide range of products, including Tru Niagen, an NAD+ booster product. 3. Analytical Reference Standards: This division specializes in the manufacturing of reference standards used in scientific research and development. Analytical Reference Standards produces high-quality reference materials and other chemical compounds. Products: Chromadex offers a wide range of products. Some of the most well-known products include: 1. Tru Niagen: Tru Niagen is Chromadex's flagship product. It is an NAD+ booster product that is intended to slow down the aging process. NAD+ is an important chemical compound that our body needs to maintain cell function. When NAD+ is depleted, it can lead to aging-related diseases. Tru Niagen acts as a "molecular booster" and increases the NAD+ level. 2. BluScience: BluScience was developed by Chromadex to offer a wide range of dietary supplements aimed at improving health and well-being. The product range includes probiotics, vitamins and minerals, and has a broad distribution market in the USA. 3. PUREnergy: PUREnergy is a natural energy drink developed by Chromadex. It combines caffeine, tea extract, and a special type of ginseng that provides energy over a longer period of time. Conclusion: Chromadex Corp is an innovative company specializing in the development of new products in the areas of health, wellness, and pharmaceuticals. It has gained an excellent reputation in the scientific community, particularly through its work in the field of NAD+ research. The wide range of products offered appeals to consumers and the constantly evolving health and wellness markets. Chromadex ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Chromadex's Sales Figures

The sales figures of Chromadex originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Chromadex’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Chromadex's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Chromadex’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Chromadex Stock

How much revenue did Chromadex generate this year?

Chromadex has achieved a revenue of 99.53 M USD this year.

How much was the turnover of the company Chromadex compared to the previous year?

The revenue of Chromadex has increased by 19.09% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Chromadex?

The revenue of Chromadex is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Chromadex measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Chromadex so important for investors?

The revenue of Chromadex is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Chromadex pay?

Over the past 12 months, Chromadex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Chromadex is expected to pay a dividend of 0 USD.

What is the dividend yield of Chromadex?

The current dividend yield of Chromadex is .

When does Chromadex pay dividends?

Chromadex pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Chromadex?

Chromadex paid dividends every year for the past 0 years.

What is the dividend of Chromadex?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chromadex located?

Chromadex is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chromadex kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chromadex from 4/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/28/2024.

When did Chromadex pay the last dividend?

The last dividend was paid out on 4/28/2024.

What was the dividend of Chromadex in the year 2023?

In the year 2023, Chromadex distributed 0 USD as dividends.

In which currency does Chromadex pay out the dividend?

The dividends of Chromadex are distributed in USD.